On February 22, 2022 ChromaDex Corp. (NASDAQ:CDXC) reported that it will hold a conference call on Wed. March 9, 2022 at 4:30 p.m. ET to discuss its financial results for the fourth quarter ended December 31, 2021 (Press release, ChromaDex, FEB 22, 2022, View Source [SID1234608785]). The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Investor Conference Call:
ChromaDex management will host an investor conference call to discuss the fourth quarter results and provide a general business update on Wed., March 9, at 4:30 p.m. ET.
Participants should call in at least 10 minutes prior to the call. The dial-in information is as follows:
Webcast link: ChromaDex Fourth Quarter 2021 Earnings Conference Call
The conference call will be broadcast live and available for replay here and via the investor relations section of the Company’s website at www.chromadex.com.
A replay of the conference call will be available from 7:30 p.m. ET on March 9, 2022, to 11:59 p.m. ET on March 16, 2022.